Health-care associated bacteremia in geriatric cancer patients with febrile neutropenia

被引:6
|
作者
Aydemir, Hande [1 ]
Piskin, Nihal [1 ]
Kokturk, Furuzan [2 ]
Gokmen, Ayla [3 ]
Akduman, Deniz [1 ]
机构
[1] Bulent Ecevit Univ, Fac Med, Dept Infect Dis & Clin Microbiol, TR-67600 Zonguldak, Turkey
[2] Bulent Ecevit Univ, Fac Med, Dept Biostat, TR-67600 Zonguldak, Turkey
[3] Bulent Ecevit Univ, Fac Med, Dept Hematol, TR-67600 Zonguldak, Turkey
关键词
Bacteremia; Neutropenia; Malignant; Febrile neutropenia; Elderly; Mortality; BLOOD-STREAM INFECTIONS; MULTINATIONAL ASSOCIATION; SUPPORTIVE CARE; RISK FEBRILE; DEFINITIONS; COHORT;
D O I
10.1016/j.jgo.2012.10.174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The aim of this study was to determine the epidemiology, clinical manifestations, and outcome of health-care associated bacteremia in geriatric cancer patients with febrile neutropenia. Materials and Methods: We retrospectively evaluated cancer patients with febrile neutropenia aged >= 60 years with culture proven health-care associated bacteremia between January 2005 and December 2011. The date of the first positive blood culture was regarded as the date of bacteremia onset. Primary outcome was the infection related mortality, defined as the death within 14 days of bacteremia onset. Results: The two most common pathogens responsible for bacteremia were Staphylococcus epidermidis (36.1%) and Escherichia coli (31.5%), with high rates of methicillin resistance and extended-spectrum beta-lactamase (ESBL) production, respectively. There were no statistically significant differences in infection related mortality rate according to the type of malignancy (p=0.776). By the univariate analysis, factors associated with 14 day mortality among febrile neutropenic episodes were prolonged neutropenia (p=0.024), persistent fever (p=0.001), hospitalization in ICU (p<0.001) and the initial clinical presentations including respiratory failure (p<0.001), hepatic failure (p=0.013), hematological failure (p<0.001), neurological failure (p<0.001), severe sepsis (p<0.001), and septic shock (p=0.036). Multivariate analysis showed that persistent fever was an independent factor associated with infection related mortality (odds ratio, 18.0; 95% confidence interval, 5.2-62.6; p<0.001). Conclusions: The only independent risk factor for mortality was persistent fever. Although the most frequently isolated pathogens were S. epidermidis and E. coli, high rates of methicillin resistance and ESBL production were found respectively. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 50 条
  • [31] Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia
    Asturias, E. J.
    Corral, J. E.
    Quezada, J.
    CURRENT ONCOLOGY, 2010, 17 (02) : 59 - 63
  • [32] Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
    Aagaard, Theis
    Reekie, Joanne
    Jorgensen, Mette
    Roen, Ashley
    Daugaard, Gedske
    Specht, Lena
    Sengelov, Henrik
    Mocroft, Amanda
    Lundgren, Jens
    Helleberg, Marie
    CANCER MEDICINE, 2020, 9 (09): : 3033 - 3042
  • [33] Febrile neutropenia in pediatric and adolescent cancer patients
    Bochennek, K.
    Simon, A.
    Laws, H. -J.
    Groll, A. H.
    Lehrnbecher, T.
    MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (05) : 443 - 450
  • [34] Factors Associated with Hospital Length of Stay among Cancer Patients with Febrile Neutropenia
    Rosa, Regis G.
    Goldani, Luciano Z.
    PLOS ONE, 2014, 9 (10):
  • [35] Febrile Neutropenia (FN) in Lung Cancer Patients
    Morocz, E.
    Lupkovics, G.
    Tolnay, E.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S617 - S617
  • [36] Circulating biomarkers for risk stratification of cancer patients with chemotherapy associated febrile neutropenia
    Wikstrom Fernandez, S.
    Torrella Esteban, P.
    Murillo Herrera, A.
    Garrido Ortega, P.
    Feliciangeli, E.
    Cerezuela-Fuentes, P.
    de Guadianae-Romualdo, L. Garcia
    ANNALS OF ONCOLOGY, 2024, 35 : S1095 - S1096
  • [37] Bloodstream infections in cancer patients with febrile neutropenia
    Feld, Ronald
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S30 - S33
  • [38] Secondary Infections in Cancer Patients with Febrile Neutropenia
    Azap, Alpay
    Bozkurt, Gulden Yilmaz
    Yuksel, Meltem Kurt
    Kutlu, Hakan
    Topcuoglu, Pervin
    Aypak, Adalet
    Akan, Hamdi
    TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (03) : 254 - 258
  • [39] Complications and costs associated with febrile neutropenia in hospitalized adult cancer patients.
    Kuderer, NM
    Crawford, J
    Dale, DC
    Lyman, GH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 531S - 531S
  • [40] Complications and mortality associated with febrile neutropenia in a Spanish multicenter cohort of patients with cancer
    Faez, L.
    Solis, M. P.
    Ramchandani, A.
    Castano, P.
    Antonio-Rebollo, M.
    Fonseca, P. J.
    Martinez-Garcia, J.
    Martinez, E.
    Puig, C. Font
    Carmona-Bayonas, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S293 - S293